DARE vs WELL · rev $1.0M vs P/E 100, rev $10.84B
Dare Bioscience Inc (DARE) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Dare Bioscience Inc (DARE) is a biotechnology company listed on US.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported DARE revenue for 2025-12-31 was $1.0M. Net income was -$13.4M. Revenue was up 10429.4% from 2024-12-31 to 2025-12-31. DARE currently screens at market cap $21.2M.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
DARE currently screens at market cap $21.2M. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the DARE and WELL stock pages for the full models.
Not investment advice.